Who
Omid Farokhzad
CEO and Chair
Company insider
Files Form 4 as: CEO and Chair, Seer; Director, Senti Biosciences Holdings; Director, Cartesian Therapeutics.
In numbers
- Trades disclosed
- 101
- Buys
- 2
- Sells
- 13
- Bought
- $223K
- Sold
- $103.2M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 27 Jun 2016
- Last trade
- 18 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Feb 2026filed 19 Feb 2026 | SEER SeerLife-science tools | SEC FORM 4 Sold | $49K24,385 at $1.99 | filing |
| 18 Feb 2026filed 19 Feb 2026 | SEER SeerLife-science tools | SEC FORM 4 Sold | $49K24,385 at $1.99 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SEER SeerLife-science tools | SEC FORM 4 Code A | —697,162 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code A | —512,000 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code A | —512,000 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SEER SeerLife-science tools | SEC FORM 4 Code A | —697,162 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code C | —1,438,057 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code C | —2,117,138 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | SEER SeerLife-science tools | SEC FORM 4 Code C | —1,438,057 | filing |
| 9 Dec 2025filed 11 Dec 2025 | SEER SeerLife-science tools | SEC FORM 4 Code C | —2,117,138 | filing |
| 19 Nov 2025filed 21 Nov 2025 | SEER SeerLife-science tools | SEC FORM 4 Sold | $67K33,838 at $1.97 | filing |
| 20 Aug 2025filed 21 Aug 2025 | SEER SeerLife-science tools | SEC FORM 4 Sold | $69K33,992 at $2.04 | filing |
| 20 May 2025filed 22 May 2025 | SEER SeerLife-science tools | SEC FORM 4 Sold | $70K33,663 at $2.08 | filing |
| 18 Feb 2025filed 20 Feb 2025 | SEER SeerLife-science tools | SEC FORM 4 Code F | $204K88,494 at $2.30 | filing |
| 4 Feb 2025filed 5 Feb 2025 | SEER SeerLife-science tools | SEC FORM 4 Sold | $18K8,068 at $2.24 | filing |
| 4 Oct 2024filed 7 Oct 2024 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code D | —878,375 | filing |
| 4 Oct 2024filed 7 Oct 2024 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code A | —878,375 | filing |
| 4 Oct 2024filed 7 Oct 2024 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code D | —532,653 | filing |
| 4 Oct 2024filed 7 Oct 2024 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code A | —532,653 | filing |
| 4 Oct 2024filed 7 Oct 2024 | SEER Seeroption or derivative · Life-science tools | SEC FORM 4 Code D | —112 | filing |
News
Seer (NASDAQ:SEER) versus BioLife Solutions (NASDAQ:BLFS) Head to Head AnalysisSEER · dailypolitical.com · 25 Oct 2026
0 headlines in the last 90 days name Omid Farokhzad; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.